Neuralink announced an FDA Breakthrough Device Designation for a speech-related application of its brain-computer interface work. The designation is presented as a regulatory milestone and not as evidence that a product is generally available or approved for routine clinical use.
Regulatory · 1 May 2025 · Neuralink
Neuralink announces FDA Breakthrough Device Designation for speech
Neuralink said its speech-focused device received FDA Breakthrough Device Designation aimed at restoring communication for people with severe speech impairment.
Neuralink announces FDA Breakthrough Device Designation for speech
Sources
Primary sources are the company’s own pages or event channels; secondary sources are independent reporting.
Primary source · 1 May 2025
Neuralink
https://neuralink.com/updates/neuralink-receives-breakthrough-device-designation-for-speech/Checked 14 Oct 2026
Related reporting
Neuralink reviews two years of Telepathy development
Clinical progress
Neuralink reviews two years of Telepathy development
Neuralink’s two-year review describes Telepathy, its clinical-participant programme and progress toward thought-controlled computer and robotic-arm interfaces.
Neuralink introduces datarepo for multimodal research data
Open source
Neuralink introduces datarepo for multimodal research data
Neuralink announced datarepo, a platform for managing multimodal data, and said its first component was being open sourced.